
MAXXING STACK
MAXXING STACK
Price range: 199,00 € through 299,00 €
The MAXXING STACK brings together three compounds from three different research fields: Retatrutide, the triple GLP-1/GIP/glucagon agonist studied in obesity trials; Melanotan II, the melanocortin agonist studied for skin pigmentation; and GHK-Cu, the copper peptide studied for skin remodeling. It is intended for research programs that examine metabolic, pigmentation and dermal endpoints side by side.
Storage
Handling & stability.
Lyophilized
Reconstituted
About this stack.
The MAXXING STACK brings together three compounds from three different research fields: Retatrutide, the triple GLP-1/GIP/glucagon agonist studied in obesity trials; Melanotan II, the melanocortin agonist studied for skin pigmentation; and GHK-Cu, the copper peptide studied for skin remodeling. It is intended for research programs that examine metabolic, pigmentation and dermal endpoints side by side.
Why these peptides
- Retatrutide: triple receptor agonist; studied in phase 2 trials in obesity and metabolic liver disease (Jastreboff 2023, Sanyal 2024).
- Melanotan II: cyclic alpha-MSH analog; examined for skin pigmentation in a pilot phase I study (Dorr 1996).
- GHK-Cu: copper tripeptide; increased collagen synthesis in fibroblasts and is examined in cosmetic studies on skin firmness (Pickart 2018).
Research Use Only. This stack contains 3 individual vials. Each item is separately packaged and sealed. Not approved for human or veterinary use. Handle with appropriate laboratory precautions.




